Literature DB >> 20660729

Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.

Anna E Burrows1, Agata Smogorzewska, Stephen J Elledge.   

Abstract

A variety of tumor-suppressor mechanisms exist to promote genome integrity and organismal survival. One such mechanism is cellular senescence. In response to replicative aging, DNA damage, and oncogenic stimuli, the p53 and Rb pathways are activated to prevent the proliferation of damaged cells by inducing senescence or apoptosis. We have performed a loss-of-function genetic screen in primary human cells to identify components of the senescence machinery. Here we describe BRD7 and BAF180 as unique regulators of replicative senescence in human cells. Both regulate p53 transcriptional activity toward a subset of its target genes required for replicative and oncogenic stress senescence induction, and BRD7 physically interacts with p53. BRD7 is a deletion target in human cancer, suggesting that loss of BRD7 may provide an additional mechanism to antagonize p53 function in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660729      PMCID: PMC2922604          DOI: 10.1073/pnas.1009559107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Selectivity of chromatin-remodelling cofactors for ligand-activated transcription.

Authors:  B Lemon; C Inouye; D S King; R Tjian
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 2.  The SWI/SNF complex--chromatin and cancer.

Authors:  Charles W M Roberts; Stuart H Orkin
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.

Authors:  M F Decristofaro; B L Betz; C J Rorie; D N Reisman; W Wang; B E Weissman
Journal:  J Cell Physiol       Date:  2001-01       Impact factor: 6.384

5.  BRD7 is a candidate tumour suppressor gene required for p53 function.

Authors:  Jarno Drost; Fiamma Mantovani; Francesca Tocco; Ran Elkon; Anna Comel; Henne Holstege; Ron Kerkhoven; Jos Jonkers; P Mathijs Voorhoeve; Reuven Agami; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2010-03-14       Impact factor: 28.824

6.  The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.

Authors:  Y Xue; J C Canman; C S Lee; Z Nie; D Yang; G T Moreno; M K Young; E D Salmon; W Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.

Authors:  David N Reisman; Janiece Sciarrotta; Weidong Wang; William K Funkhouser; Bernard E Weissman
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

8.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  A resource for large-scale RNA-interference-based screens in mammals.

Authors:  Patrick J Paddison; Jose M Silva; Douglas S Conklin; Mike Schlabach; Mamie Li; Shola Aruleba; Vivekanand Balija; Andy O'Shaughnessy; Lidia Gnoj; Kim Scobie; Kenneth Chang; Thomas Westbrook; Michele Cleary; Ravi Sachidanandam; W Richard McCombie; Stephen J Elledge; Gregory J Hannon
Journal:  Nature       Date:  2004-03-25       Impact factor: 49.962

10.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

View more
  80 in total

1.  Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression.

Authors:  Fuhua Xu; Stephen Flowers; Elizabeth Moran
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 2.  The dynamic interplay in chromatin remodeling factors polycomb and trithorax proteins in response to DNA damage.

Authors:  Shuang Liu; Yongguang Tao; Xiang Chen; Ya Cao
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

Review 3.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

4.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.

Authors:  Ke Xu; Wei Xiong; Ming Zhou; Heran Wang; Jing Yang; Xiayu Li; Pan Chen; Qianjin Liao; Hao Deng; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng
Journal:  Mol Cell Biochem       Date:  2015-09-25       Impact factor: 3.396

5.  Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.

Authors:  Wenhua Gao; Wei Li; Tengfei Xiao; Xiaole Shirley Liu; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-12       Impact factor: 11.205

Review 6.  The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.

Authors:  Lili Liao; Joseph R Testa; Haifeng Yang
Journal:  Cancer Genet       Date:  2015-02-20

Review 7.  A primer on using pooled shRNA libraries for functional genomic screens.

Authors:  Guang Hu; Ji Luo
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-02       Impact factor: 3.848

8.  A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors.

Authors:  Lior Izhar; Britt Adamson; Alberto Ciccia; Jedd Lewis; Laura Pontano-Vaites; Yumei Leng; Anthony C Liang; Thomas F Westbrook; J Wade Harper; Stephen J Elledge
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

9.  Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

Authors:  Kaishun Hu; Wenjing Wu; Yu Li; Lehang Lin; Dong Chen; Haiyan Yan; Xing Xiao; Hengxing Chen; Zhen Chen; Yin Zhang; Shuangbing Xu; Yabin Guo; H Phillip Koeffler; Erwei Song; Dong Yin
Journal:  EMBO Rep       Date:  2019-04-02       Impact factor: 8.807

10.  BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.

Authors:  Yu-Hsin Chiu; Jennifer Y Lee; Lewis C Cantley
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.